Periodontal (gum) disease is a chronic inflammation initiated by bacteria that affect the gums and bone supporting the teeth, and may eventually result in tissue and tooth loss. It is similar to other ...

This story is one of many exploring recent advances in the science of longevity and aging. Topics include musculoskeletal health, cognitive health, genetic predisposition to disease, inflammation, and ...

Resolvins, a recently discovered family of endogenous omega-3 fatty-acid-derived mediators with potent immunoregulatory effects, could be novel analgesics for the treatment of inflammatory pain. The ...

April 6 -- SATURDAY, April 4 (HealthDay News) -- Resolvins, a new family of biologically active products of omega-3 fatty acids, may be able to remedy the inflammation of periodontal disease and ...

Researchers have discovered that the remains of tumor cells killed by chemotherapy or other cancer treatments can actually stimulate tumor growth by inducing an inflammatory reaction. The study also ...

BEDFORD, MA –August, 24, 2009 -- Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced positive data from a Phase 2 clinical study evaluating RX-10045, a resolvin ...

Inflammation, Pain, and Resolvins Not all inflammation leads to pain. Despite widespread infection followed by fever, colds rarely cause pain. But when some cytokines and certain immune cells are ...

BEDFORD, Mass. -- Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced that it has raised $25 million in a Series B financing led by funds managed by QVT ...

Periodontal (gum) disease is a chronic inflammation initiated by bacteria that affect the gums and bone supporting the teeth, and may eventually result in tissue and tooth loss. It is similar to other ...